Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes

Abstract excerpt

Although immune-checkpoint inhibitors (ICIs) have significantly improved cancer treatment, their effectiveness is limited by primary or acquired resistance in many patients. The gut microbiota, through its production of metabolites and regulation of immune cell functions, plays a vital role in maintaining immune balance and influencing the response to cancer immunotherapies. This review highlights evidence...

Topics

Join the communities discussing this publication.

• Clostridium difficile and Clostridium perfringens research
• Gut microbiota and health
• Tryptophan and brain disorders